An altered scaffolding function of NEDD9 protein, which is critical in sustaining numerous pro-oncogenic and tumor-suppressing pathways that are extensively cross-regulated, has been extensively reported in the literature in several cancer settings, including NSCLC [24,43]. The gene discussed is NEDD9; the disease is neoplasm.